Personomics: The Missing Link in the Evolution from Precision Medicine to Personalized Medicine

被引:35
|
作者
Ziegelstein, Roy C. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
来源
JOURNAL OF PERSONALIZED MEDICINE | 2017年 / 7卷 / 04期
关键词
personomics; precision medicine; health care; personalized medicine; BREAST-CANCER; HEALTH-CARE; CHEMOTHERAPY; LAPATINIB; METAANALYSIS; TRASTUZUMAB; COMBINATION; RECEPTOR; PLUS;
D O I
10.3390/jpm7040011
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Clinical practice guidelines have been developed for many common conditions based on data from randomized controlled trials. When medicine is informed solely by clinical practice guidelines, however, the patient is not treated as an individual, but rather as member of a group. Precision medicine, as defined herein, characterizes unique biological characteristics of the individual or of specimens obtained from an individual to tailor diagnostics and therapeutics to a specific patient. These unique biological characteristics are defined by the tools of precision medicine: genomics, proteomics, metabolomics, epigenomics, pharmacogenomics, and other "-omics." Personalized medicine, as defined herein, uses additional information about the individual derived from knowing the patient as a person. These unique personal characteristics are defined by the tools of personalized medicine-personomics-which take into account an individual's personality, preferences, values, goals, health beliefs, social support network, financial resources, and unique life circumstances that affect how and when a given health condition will manifest in that person and how that condition will respond to treatment. In this paradigm, precision medicine may be considered a necessary step in the evolution of medical care to personalized medicine, with personomics as the missing link.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Restoring the missing person to personalized medicine and precision psychiatry
    Gomez-Carrillo, Ana
    Paquin, Vincent
    Dumas, Guillaume
    Kirmayer, Laurence J.
    [J]. FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [2] Personalized medicine or precision medicine?
    Faiz, Kashif Waqar
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (01) : 84 - 84
  • [3] Precision medicine or personalized medicine?
    Caplan, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 30 - 30
  • [4] Oncology in 2012: from personalized medicine to precision medicine
    Morere, J. F.
    [J]. TARGETED ONCOLOGY, 2012, 7 (04) : 211 - 212
  • [5] From strata and personalized medicine to precision medicine in oncology
    Salas-Gonzalez, Efrain
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (04): : 125 - 126
  • [6] Oncology in 2012: from personalized medicine to precision medicine
    J. F. Morere
    [J]. Targeted Oncology, 2012, 7 : 211 - 212
  • [7] Host-dependent variables: The missing link to personalized medicine
    Demlova, Regina
    Zdrazilova-Dubska, Lenka
    Sterba, Jaroslav
    Stanta, Giorgio
    Valik, Dalibor
    [J]. EJSO, 2018, 44 (09): : 1289 - 1294
  • [8] From Personalized Medicine to Precision Psychiatry?
    Ceskova, Eva
    Silhan, Petr
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 3663 - 3668
  • [9] From personalized to precision cancer medicine
    Baltagiannis, Evangelos G.
    Kyrochristos, Ioannis D.
    Ziogas, Demosthenes E.
    Goussia, Anna
    Mitsis, Michail
    Roukos, Dimitrios H.
    [J]. PERSONALIZED MEDICINE, 2020, 17 (04) : 245 - 250
  • [10] Personalized precision medicine
    Konieczny, Leszek
    Roterman, Irena
    [J]. BIO-ALGORITHMS AND MED-SYSTEMS, 2019, 15 (04)